# Efficacy and Safety of NestaCell® in Huntington's Disease

> **NCT06097780** · PHASE3 · UNKNOWN · sponsor: **Azidus Brasil** · enrollment: 120 (estimated)

## Conditions studied

- Huntington Disease

## Interventions

- **GENETIC:** NestaCell®

## Key facts

- **NCT ID:** NCT06097780
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-06-08
- **Primary completion:** 2025-09-08
- **Final completion:** 2026-02-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06097780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06097780, "Efficacy and Safety of NestaCell® in Huntington's Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06097780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*